These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 5123910)

  • 1. Aluminium in bone from patients with renal failure.
    Parsons V; Davies C; Goode C; Ogg C; Siddiqui J
    Br Med J; 1971 Oct; 4(5782):273-5. PubMed ID: 5123910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum aluminium concentration and aluminium deposits in bone in patients receiving haemodialysis.
    Charhon SA; Chavassieux PM; Meunier PJ; Accominotti M
    Br Med J (Clin Res Ed); 1985 Jun; 290(6482):1613-4. PubMed ID: 3924189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Measurement of aluminium in bone by pulse polarography (author's transl)].
    Burnel D; Hutin MF; Netter P; Kessler M; Huriet C; Gaucher A
    Pathol Biol (Paris); 1982 Jan; 30(1):27-32. PubMed ID: 7038598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutron activation analysis of a hand-a method of monitoring progressive bone disease.
    McIntosh JA; Catto GR
    Biomed Eng; 1974 Jun; 9(6):254-6 passim. PubMed ID: 4837582
    [No Abstract]   [Full Text] [Related]  

  • 5. Changes in bone histoquantitative parameters and histochemical staining reactions for aluminium in a group of patients with chronic renal failure following a reduction in the aluminium concentration of the haemodialysis fluid.
    McClure J; Fazzalari NL; Fassett RG; Pugsley PG
    J Clin Pathol; 1984 Jul; 37(7):743-7. PubMed ID: 6747011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of aluminium and magnesium effects on initiation and promotion of renal osteodystrophy in patients with chronic renal failure].
    Nakamrua M; Sato N; Tsukamoto Y; Marumo F; Iwanami S
    Nihon Jinzo Gakkai Shi; 1986 Apr; 28(4):421-8. PubMed ID: 3747253
    [No Abstract]   [Full Text] [Related]  

  • 7. The efficacy of various treatment modalities on aluminium associated bone disease.
    Ihle BU; Buchanan MR; Stevens B; Becker GJ; Kincaid-Smith P
    Proc Eur Dial Transplant Assoc; 1983; 19():195-202. PubMed ID: 6348735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localisation of aluminium by histochemical and electron probe x-ray microanalytical techniques in bone tissue of cases of renal osteodystrophy.
    Smith PS; McClure J
    J Clin Pathol; 1982 Nov; 35(11):1283-93. PubMed ID: 7142436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between hair, serum and bone aluminium in hemodialyzed patients.
    Chappuis P; de Vernejoul MC; Paolaggi F; Rousselet F
    Clin Chim Acta; 1989 Feb; 179(3):271-8. PubMed ID: 2714000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The early effects of aluminium deposition and dialysis on bone in chronic renal failure: a cross-sectional bone-histomorphometric study.
    Dahl E; Nordal KP; Halse J; Flatmark A
    Nephrol Dial Transplant; 1990; 5(6):449-56. PubMed ID: 2122323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scalp hair as an indicator of aluminium exposure: comparison to bone and plasma.
    Wilhelm M; Passlick J; Busch T; Szydlik M; Ohnesorge FK
    Hum Toxicol; 1989 Jan; 8(1):5-9. PubMed ID: 2785480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Aluminum and uremic bone disease. Diagnostic utility of serum aluminum and the deferoxamine (DFO) test ].
    Jarava C; Armas JR; Palma A
    Nefrologia; 2001; 21(2):174-81. PubMed ID: 11464651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of fracturing renal osteodystrophy by desferrioxamine.
    Ackrill P; Day JP; Garstang FM; Hodge KC; Metcalfe PJ; Benzo Z; Hill K; Ralston AJ; Ball J; Denton J
    Proc Eur Dial Transplant Assoc; 1983; 19():203-7. PubMed ID: 6878234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bone disorders in children with chronic renal insufficiency exposed to high ingestion of aluminum].
    Gordillo-Paniagua G; Valencia-Mayoral P; Mercado L; Medina-Mercado M
    Bol Med Hosp Infant Mex; 1990 May; 47(5):336-41. PubMed ID: 2390188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone lead in dialysis patients.
    Van de Vyver FL; D'Haese PC; Visser WJ; Elseviers MM; Knippenberg LJ; Lamberts LV; Wedeen RP; De Broe ME
    Kidney Int; 1988 Feb; 33(2):601-7. PubMed ID: 3129611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deranged Ca, Al and Mg content in the tissues of patients with chronic renal failure, as measured by non-destructive neutron activation analysis.
    Marumo F; Nakamura M; Sato N; Shimada H; Tsukamoto S; Iwanami S
    Int J Artif Organs; 1985 Nov; 8(6):319-24. PubMed ID: 4077290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective evaluation of aluminum loading from formula in infants with uremia.
    Salusky IB; Coburn JW; Nelson P; Goodman WG
    J Pediatr; 1990 May; 116(5):726-9. PubMed ID: 2329421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone aluminium in haemodialysed patients and in rats injected with aluminium chloride: relationship to impaired bone mineralisation.
    Ellis HA; McCarthy JH; Herrington J
    J Clin Pathol; 1979 Aug; 32(8):832-44. PubMed ID: 389958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-response relationships in aluminium toxicity in humans.
    Coulson JM; Hughes BW
    Clin Toxicol (Phila); 2022 Apr; 60(4):415-428. PubMed ID: 35179097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone fluoride in patients with uremia maintained by chronic hemodialysis.
    Kim D; Del Greco F; Hefferen JJ; Levin NW
    Trans Am Soc Artif Intern Organs; 1970; 16():474-8. PubMed ID: 5454201
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.